临床药师参与1例急性髓细胞白血病合并鼻脑型毛霉病患者的诊疗实践
x
请在关注微信后,向客服人员索取文件
篇名: | 临床药师参与1例急性髓细胞白血病合并鼻脑型毛霉病患者的诊疗实践 |
TITLE: | Practice of clinical pharmacists participating in the diagnosis and treatment for a patient with rhinocerebral mucormycosis with acute myelocytic leukemia |
摘要: | 目的 为急性髓细胞白血病合并鼻脑型毛霉病的诊疗提供参考。方法临床药师参与1例急性髓细胞白血病合并鼻脑型毛霉病患者的诊疗过程。临床药师通过查阅文献,根据患者基础疾病、临床表现、用药史,发现其鼻脑型毛霉病可能性大,建议医师及时进行诊断性检查,并建议使用注射用两性霉素B脂质体200mg,qd进行针对性治疗。在使用两性霉素B脂质体期间,临床药师对患者、医护人员进行了用药教育和指导,并通过每日药学查房对可能发生的不良反应进行监测。结果患者体温恢复正常,感染得到控制,使用两性霉素B脂质体期间并未发生不能耐受的不良反应,且停药后6个月未见复发。结论对于有鼻脑型毛霉病高危因素的患者,可根据其临床表现,结合既往抗感染药物使用史、实验室检查结果综合判断毛霉菌感染的风险;在进行诊断性检查的同时,可经验性使用针对性药物进行治疗,以降低病死率。毛霉菌感染的首选药物为两性霉素B脂质体,但长期、大剂量使用会增加患者不良反应发生风险,应及早采取措施干预并做好患者的用药教育,提高其依从性,保证用药剂量和疗程足够。 |
ABSTRACT: | OBJECTIVE To provide reference for the diagnosis a nd treatment for rhinocerebral mucormycosis complicated with acute myelocytic leukemia . METHODS Clinical pharmacists were involved in the diagnosis and treatment of rhinocerebral mucormycosis complicated with acute myelocytic leukemia . Through literature review , clinical pharmacists found that mucormycosis was highly likely according to the patient ’s underlying diseases ,clinical manifestations and medication history ,and suggested the doctors to conduct diagnostic examination in a timely manner ,and recommended Amphotericin B liposome for injection 200 mg once a day for targeted treatment . During the administration of amphotericin B liposome ,clinical pharmacists educated and instructed patientand medical staff about the drug use and monitored patient for possible adverse drug reactions through daily pharmaceutical ward round . RESULTS The patient ’s body temperature returned to normal ,infection was controlled , and there was no intolerable adverse drug reactions during treatment . No recurrence was observed 6 months after amphotericin B liposome was discontinued . CONCLUSIONS For patients with high risk factors of rhinocerebral mucormycosis ,the risk of mucormycosis can be comprehensively judged according to their clinical manifestations ,combined with history of anti -infective drug use and the results of laboratory examination . At the same time of diagnostic examination ,targeted drugs can be empirically used to reduce the mortality . Amphotericin B liposome is the first choice for mucormycosis ,but long -term use and high dose will increase the risk of adverse drug reactions in patients . Early intervention measures should b e taken and medication education should be done for patients to improve their compliance and ensure adequate dosage and course of treatment . |
期刊: | 2022年第33卷第20期 |
作者: | 陶春,石敏,黄玉,李艳钰,肖溢 |
AUTHORS: | TAO Chun ,SHI Min,HUANG Yu,LI Yanyu ,XIAO Yi |
关键字: | 急性髓细胞白血病;鼻脑型毛霉病;诊断;两性霉素B脂质体;药品不良反应;临床药师;诊疗实践 |
KEYWORDS: | acute myelocytic leukemia ; rhinocerebral |
阅读数: | 193 次 |
本月下载数: | 15 次 |
* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!